尿路上皮肿瘤患者应用吉西他滨和奥沙利铂治疗的临床效果
李震
（西安市第四医院外三科，陕西 西安，710004）
浏览次数：89次 下载次数：298次
摘要：
目的 探讨吉西他滨联合奥沙利铂治疗尿路上皮肿瘤的临床效果。方法 选取我科收治的52例尿路上皮肿瘤患者为研 究对象，按治疗方案不同分为对照组（n=26）与观察组（n=26）。对照组患者单纯采用吉西他滨治疗，观察组患者采用吉西他滨+奥沙利铂治疗。比较两组患者的临床效果及药物不良反应发生情况。结果 观察组患者治疗总有效率为66.67%，临床控制 率为87.50%；对照组治疗总有效率为43.48%，临床控制率为73.91%，观察组患者总有效率及临床控制率明显高于对照组（P<0.05）；观察组药物不良反应总发生率为25.00%，明显低于对照组的47.83%，差异有统计学意义（P<0.05）。结论 与单纯采用吉西他滨相比，吉西他滨联合奥沙利铂治疗尿路上皮肿瘤临床效果更显著，安全性更高，值得在临床中推广使用。
关键词：吉西他滨；奥沙利铂；尿路上皮肿瘤
中图分类号：R737.1文献标志码：A文章编号：2096-1413(2017)34-0024-02
Clinical effect of gemcitabine combined with oxaliplatin in the treatment of urothelial tumors
LI Zhen
(No.3 Department of Surgery, Xi``an No.4 Hospital, Xi``an 710004, China)
ABSTRACT: Objective To investigate the effect of gemcitabine combined with oxaliplatin in the treatment of urothelial tumors. Methods Fifty-two urothelial tumors patients were selected and divided into control group (n=26) and observation group (n=26) according to different treatment methods. The control group was given gemcitabine alone, and the observation group was treated with gemcitabine combined with oxaliplatin. The clinical efficacy and adverse reactions incidence rate of the two groups were compared. Results The total effective rate and clinical control rate of the observation group were 66.67% and 87.50% respectively, which were significantly higher than 43.48% and 73.91% of the control group (P<0.05). The total incidence rate of adverse reaction of the observation group was 25.00%, which was lower than 47.83% of the control group (P<0.05). Conclusion Compared with gemcitabine alone, gemcitabine combined with oxaliplatin in the treatment of urothelial tumors has more significant efficacy and higher safety, which is worthy of clinical application and promotion.
KEYWORDS: gemcitabine; oxaliplatin; urothelial tumors
参考文献：
[1] 杜智勇,秦川,申忠华,等.高风险上尿路尿路上皮癌辅助化疗疗效分析及预后相关因素研究[J].中华泌尿外科杂志,2016,37(11):808-812.
[2] 黄小华,刘叶.吉西他滨联合奥沙利铂治疗尿路上皮肿瘤的疗效及安全性[J].实用中西医结合临床,2014,14(12):9-10.
[3] 张俊凯,潘佩玲,吴颖猛,等.吉西他滨联合多西他赛或顺铂治疗晚期尿路上皮移行细胞癌的临床研究[J].中国肿瘤临床与康复,2011,18(5):431-434.
[4] 魏勇,张庭,李蓓.吉西他滨联合奥沙利铂治疗尿路上皮肿瘤的疗效[J].中国老年学,2013,33(22):5579-5580.
[5] 张子旭.吉西他滨双药联合化疗对比单药化疗治疗晚期胰腺癌的疗效与安全性的Meta 分析[J].中国药房,2013,24(32):3039-3042.
[6] 陈茹,王晨宇,李九智,等.吉西他滨联合顺铂方案治疗晚期尿路上皮癌的疗效评价[J].医药前沿,2012,6(27):79-80.